Table 7.
Characteristic | Patients With Prolonged (>1 Year) Opioid Use After Fusion | Patients Without Prolonged Opioid Use After Fusion | P |
---|---|---|---|
Total patients | 8740 | 4517 | n/a |
Male | 3458 (39.6) | 1928 (42.7) | <.001 |
Female | 5282 (60.4) | 2589 (57.3) | |
Average LOS (days) | 8.05 (SD = 7.9) | 7.62 (SD = 6.4) | <.001 |
Geographical region breakdown | |||
Midwest | 2002 (22.9) | 1220 (27.0) | <.0001 |
Northeast | 159 (1.8) | 117 (2.6) | |
South | 5649 (64.6) | 2712 (60.0) | |
West | 930 (10.6) | 468 (10.4) | |
Race breakdown | |||
Unknown | 728 (8.3) | 574 (12.7) | <.0001 |
White | 7149 (81.8) | 3578 (79.2) | |
Black | 673 (7.7) | 253 (5.6) | |
Other | 64 (0.7) | 43 (1.0) | |
Asian | 19 (0.2) | 14 (0.3) | |
Hispanic | 86 (1.0) | 46 (1.0) | |
North American Native | 21 (0.2) | 9 (0.2) | |
Preoperative comorbidities | |||
Obesity (BMI >30 kg/m2) | 2145 (24.5) | 918 (20.3) | <.0001 |
Any opioid use 6 months prior to fusion | 5982 (68.4) | 1674 (37.1) | <.05 |
Smoker | 1778 (20.3) | 517 (11.4) | <.05 |
Type 2 diabetes mellitus | 3236 (37.0) | 1587 (35.1) | <.05 |
Abbreviations: BMI, body mass index; LOS, length of stay; n/a, not applicable; SD, standard deviation.